Pessimistic Response to FDA Leadership Charge  

Oleh:

Kling, Jim

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 11 (Nov. 2005), page 1325.
Topik: LEADERSHIPS; pessimistic response. FDA leadership change

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.4 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In september, lester crawford resigned as comminssioner of the US food and drug adimistration (FDA), leaving a leadership vacuum that was quickly dilled by president bush's appointment of andrew president bush's appointment of andrew von eschenbach, formerly the director of the national cancer institute (NCI) as acting commissioner. the lack of certainty in the FDA leadership is likely to further stultify agency decision making and force biotech companies to stic to pharmaceutical alliances rather than going it alone in seeking drug approval.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali